While plasma levels of osteopontin, a bone sialoprotein, have shown to exhibit predictive value regarding tumor hypoxia and the potential benefit of the hypoxia modifier nimorazole [44, 45], osteopontin was also found to be abundantly secreted by immunosenescent T cells [46, 47]. The gene discussed is SPP1; the disease is neoplasm.